Previous close | 3.0500 |
Open | 3.0900 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 2.8750 - 3.0900 |
52-week range | 1.9382 - 4.4500 |
Volume | |
Avg. volume | 52,725 |
Market cap | 111.994M |
Beta (5Y monthly) | 1.73 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
We can readily understand why investors are attracted to unprofitable companies. For example, although...
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2024 Earnings Call Transcript May 11, 2024 DiaMedica Therapeutics Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics First Quarter 2024 Conference Call. An […]
Multiple insiders secured a larger position in DiaMedica Therapeutics Inc. ( NASDAQ:DMAC ) shares over the last 12...